CNBC January 19, 2018
Fred Hassan, Chairman, Caret Group & Special Limited Partner, Warburg Pincus, LLC

  • Health care was one of the top sectors in 2017 investment inflows, at $4 billion, outpaced only by the internet, at $6.5 billion.
  • The cost of sequencing a genome is under $1,000, down from $2 billion less than two decades ago; 1 billion people will soon supply the world’s databases with their genomic and phenotypic information.
  • 46 new products were approved in 2017, double the number 10 years ago.
  • Fred Hassan is an advisory board member for Healthy Returns, CNBC’s new health-care innovation conference, on March 28, 2018, in New York City.

This year’s emergence of breakthrough innovations illustrates the vitality of the health care industry. And biopharma is largely what’s underpinning this paradigm shift in the global...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Investments, Pharma, Precision Medicine
Growing gulf in US life expectancy deepened by COVID-19 pandemic
Stick to the Science
Shifting Our Healthcare Delivery Model from Reactive to Proactive
Collecting, Using, and Exchanging Data to Advance Health and Health Equity
A 'straight-A' hospital's safety playbook

Share This Article